Volume 99, Issue 7

Search all Annals of Hematology articles

July 2020

32 articles in this issue

Hematological findings in coronavirus disease 2019: indications of progression of disease
Xiaoqing Liu
Run Zhang
Guangsheng He
Review Article 03 June 2020 Pages: 1421 - 1428
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
Jannik Stemler
Philipp Koehler
Oliver A. Cornely
Review Article Open access 08 June 2020 Pages: 1429 - 1440
Modern management of splenomegaly in patients with myelofibrosis
Douglas Tremblay
Myron Schwartz
John Mascarenhas
Review Article 17 May 2020 Pages: 1441 - 1451
Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia
Rahyssa Rodrigues Sales
André Rolim Belisário
Marcos Borato Viana
Original Article 23 May 2020 Pages: 1453 - 1463
Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country
Marina García-Morín
Eduardo J. Bardón-Cancho
Elena Cela
Original Article 26 May 2020 Pages: 1465 - 1474
Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India
Priya Hariharan
Pooja Kishnani
Anita Nadkarni
Original Article 10 June 2020 Pages: 1475 - 1483
Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study
Zesong Chen
Miao Chen
Bing Han
Original Article 01 June 2020 Pages: 1485 - 1491
Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
Ka-Won Kang
Hyemi Moon
Yong Park
Original Article 15 June 2020 Pages: 1493 - 1503
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
Hubert Schrezenmeier
Alexander Röth
Jaroslaw P. Maciejewski
Original Article Open access 10 May 2020 Pages: 1505 - 1514
Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis
Isao Tsuboi
Tomonori Harada
Shin Aizawa
Original Article 06 June 2020 Pages: 1515 - 1523
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
Olga Mulas
Giovanni Caocci
Giorgio La Nasa
Original Article 30 May 2020 Pages: 1525 - 1530
LPS-induced expression and release of monocyte tissue factor in patients with haemophilia
Katharina Holstein
Anna Matysiak
Florian Langer
Original Article Open access 19 May 2020 Pages: 1531 - 1542
Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis
Stella V. Koval
Daniil F. Gluzman
Yaroslava I. Vyhovska
Original Article 19 May 2020 Pages: 1543 - 1550
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
Heiko Becker
Dietmar Pfeifer
Michael Lübbert
Original Article Open access 06 June 2020 Pages: 1551 - 1560
A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction
Zhao Cheng
Yunya Luo
Guangsen Zhang
Original Article 26 May 2020 Pages: 1561 - 1564
Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders
Mizuki Watanabe
Junya Kanda
Akifumi Takaori-Kondo
Original Article 20 May 2020 Pages: 1565 - 1573
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis—a dangerous disease
Zhili Jin
Yini Wang
Zhao Wang
Original Article 04 June 2020 Pages: 1575 - 1581
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)
Andrea Janikova
Jozef Michalka
Marek Trneny
Original Article 06 June 2020 Pages: 1583 - 1594
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Clara Sortais
Anne Lok
Steven Le Gouill
Original Article 16 May 2020 Pages: 1595 - 1604
R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study
T. Systchenko
G. Defossez
P. Ingrand
Original Article 25 May 2020 Pages: 1605 - 1613
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study
Jeremie Zerbit
Sylvie Chevret
Catherine Thieblemont
Original Article Open access 01 June 2020 Pages: 1615 - 1625
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
A. Muntañola
T. Baumann
J. M. Sancho
Original Article 25 May 2020 Pages: 1627 - 1634
Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group
Masatoshi Sakurai
Takehiko Mori
Ritsuro Suzuki
Original Article 18 May 2020 Pages: 1635 - 1642
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia
Qi Chen
Xin Zhao
Xiao-hui Zhang
Original Article 26 May 2020 Pages: 1643 - 1653
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation
Satoshi Kaito
Atsushi Wada
Noriko Doki
Original Article 10 June 2020 Pages: 1655 - 1665
Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma
Taku Kikuchi
Jun Kato
Takehiko Mori
Letter to the Editor 06 June 2020 Pages: 1667 - 1668
Acquired amegakaryocytic thrombocytopenic purpura possibly induced by anti-PD-1 antibody
Satoshi Iyama
K. Takada
M. Kobune
Letter to the Editor 04 May 2020 Pages: 1669 - 1670
Uterine myeloid sarcoma
Giovanni Martino
Magda Zanelli
Stefano Ascani
Letter to the Editor 04 May 2020 Pages: 1671 - 1672
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
Nil Albiol
Rahinatu Awol
Rodrigo Martino
Letter to the Editor 28 May 2020 Pages: 1673 - 1674
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Giovanni Caocci
Giorgio La Nasa
Letter to the Editor 14 May 2020 Pages: 1675 - 1676
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone
Giuseppe Visani
Martina Chiarucci
Alessandro Isidori
Letter to the Editor 13 June 2020 Pages: 1677 - 1678
COVID-19 infection associated with autoimmune hemolytic anemia
Antoine Capes
Sarah Bailly
Pierre-François Laterre
Letter to the Editor 16 June 2020 Pages: 1679 - 1680

Volume 99, Issue 7

Hematological findings in coronavirus disease 2019: indications of progression of disease

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma

Modern management of splenomegaly in patients with myelofibrosis

Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia

Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country

Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India

Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study

Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry

Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis

Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors

LPS-induced expression and release of monocyte tissue factor in patients with haemophilia

Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia

A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction

Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders

Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis—a dangerous disease

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group

Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group

Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia

Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation

Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma

Acquired amegakaryocytic thrombocytopenic purpura possibly induced by anti-PD-1 antibody

Uterine myeloid sarcoma

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone

COVID-19 infection associated with autoimmune hemolytic anemia

Navigation